美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Drugs Made in America Acquisition Corp.

10.17

+0.01010.10%

成交量：4.78萬

成交額：48.50萬

市值：3.41億

市盈率：-181.71

高：10.18

開：10.00

低：10.00

收：10.16

資料載入中...

總覽公司新聞資訊公告

重要事件披露

Form 8-K - Current report

重要事件披露

Form 8-K - Current report

重要事件披露

Form 8-K - Current report

SEC問詢函

Form CORRESP - Correspondence

SEC問詢函

Form CORRESP - Correspondence

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC問詢函

Form CORRESP - Correspondence

SEC問詢函

Form CORRESP - Correspondence

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC問詢函

Form CORRESP - Correspondence

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DMAAU/filings"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMAAU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAAU\",,,,,undefined,":{"symbol":"DMAAU","market":"US","secType":"STK","nameCN":"Drugs Made in America Acquisition Corp.","latestPrice":10.1701,"timestamp":1745611200000,"preClose":10.16,"halted":0,"volume":47753,"delay":0,"floatShares":28958338,"shares":33517100,"eps":-0.055968,"marketStatus":"休市中","change":0.0101,"latestTime":"04-25 16:00:00 EDT","open":10,"high":10.18,"low":10,"amount":484977.4,"amplitude":0.017717,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.055968,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"listingDate":1736744400000,"exchange":"NASDAQ","adjPreClose":10.16,"volumeRatio":56.07444151309986},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAAU\",,,,,undefined,":{"symbol":"DMAAU","floatShares":28958338,"roa":"--","roe":"--","lyrEps":-0.032648,"volumeRatio":56.07444151309986,"shares":33517100,"dividePrice":0,"high":10.18,"amplitude":0.017717,"preClose":10.16,"low":10,"week52Low":10,"pbRate":"-1392.20","week52High":10.82,"institutionHeld":0,"latestPrice":10.1701,"eps":-0.055968,"divideRate":0,"volume":47753,"delay":0,"ttmEps":-0.055968,"open":10,"prevYearClose":10,"prevWeekClose":10.16,"prevMonthClose":10.17,"prevQuarterClose":10.17,"fiveDayClose":10.16,"twentyDayClose":10.17,"sixtyDayClose":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"DMAAU\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"19159975","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025016602-DMAAU","pdf_url":"","pub_time":1740373200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAAU","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016602/0001213900-25-016602-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED FEBRUARY 20, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016602/ea023198001ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea023198001ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEEu27NiT1wNDHwq41","market":"us","size":7834},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016602/ea0231980-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0231980-8k_drugs.htm","type":"8-K","id":"NTFILEHEzqDtFcVKNBHG7i","market":"us","size":18833}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-24 13:00","pubTimestamp":1740373200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他事件；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19114003","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025010079-DMAAU","pdf_url":"","pub_time":1738645200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAAU","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/0001213900-25-010079-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED JANUARY 29, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/ea022985301ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea022985301ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILE7tohg9b5Vw3icFfx","market":"us","size":137733},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/ea0229853-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0229853-8k_drugs.htm","type":"8-K","id":"NTFILE9XaupnAWaPvb91as","market":"us","size":33315}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-04 13:00","pubTimestamp":1738645200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他事件；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19088892","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025008377-DMAAU","pdf_url":"","pub_time":1738271452000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAAU","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-008377-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED JANUARY 27, 2025, BY AND BETWEEN THE COMPANY AND C","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex1-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea022913501ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE3HPboxW3CKeSxs5V","market":"us","size":244779},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea0229135-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0229135-8k_drugs.htm","type":"8-K","id":"NTFILEF7kEXyqmMy7YPMNm","market":"us","size":37390},{"description":"SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex3-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex3-1_drugs.htm","type":"EX-3.1","id":"NTFILE4vYp5Y79fRfxZ2PU","market":"us","size":341912},{"description":"RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND BETWEEN THE COMPANY AND VSTOCK T","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEAL4mCSpVEZHfJaXE","market":"us","size":68171},{"description":"LETTER AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY, DRUGS MADE IN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILEDwVQah3i8Hk5zSRF","market":"us","size":46260},{"description":"INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE C","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-2_drugs.htm","type":"EX-10.2","id":"NTFILEiKE5cHQdtNpzizuc","market":"us","size":104109},{"description":"REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY A","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEDxYakT5Q7KAWrZh8","market":"us","size":103717},{"description":"AMENDED AND RESTATED PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED JANUARY 27, 202","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILEC2qAYL9hqVL5zACX","market":"us","size":25588},{"description":"FORM OF INDEMNITY AGREEMENT BY AND BETWEEN THE COMPANY AND EACH OF THE OFFICERS","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILEDnMRgpoahunxQ7SL","market":"us","size":81921},{"description":"ADMINISTRATIVE SERVICES AGREEMENT, DATED AS OF JANUARY 7, 2025, BY AND BETWEEN T","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILE7YHuhSBWipoT9Tb3","market":"us","size":10843},{"description":"NOTE CONVERSION AGREEMENT, DATED AS OF JANUARY 29, 2025, BY AND BETWEEN THE COMP","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-7_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-7_drugs.htm","type":"EX-10.7","id":"NTFILEBz97RvMJSx7iv5oE","market":"us","size":19862},{"description":"PROMISSORY NOTE, DATED AS OF JANUARY 29, 2025, ISSUED TO DRUGS MADE IN AMERICA A","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-8_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-8_drugs.htm","type":"EX-10.8","id":"NTFILE3cSB46hNvZESiHgY","market":"us","size":26140},{"description":"PRESS RELEASE DATED JANUARY 27, 2025","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex99-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILE9b8vLyNC6sKwuaeB","market":"us","size":8449},{"description":"PRESS RELEASE DATED JANUARY 29, 2025","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex99-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex99-2_drugs.htm","type":"EX-99.2","id":"NTFILE8rFk5TCnuFCsGnV1","market":"us","size":7942},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILE4NdsJuv3LKExeGNp","market":"us","size":17938},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ex3-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_002.jpg","type":"GRAPHIC","id":"NTFILEFzD565aH3QtDCsfq","market":"us","size":7532}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-01-31 05:10","pubTimestamp":1738271452,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：簽訂重大最終協議；第3.02項：未經登記的股本證券銷售；第5.03項：公司章程或章程的修訂；財政年度的變化；項目8.01：其他事件；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19141928","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025005828-DMAAU","pdf_url":"","pub_time":1737608400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAAU","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005828/0001213900-25-005828-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005828/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHQKGBKTvWLVELCV1","market":"us","size":7176}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-01-23 13:00","pubTimestamp":1737608400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19141920","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025005825-DMAAU","pdf_url":"","pub_time":1737608400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAAU","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005825/0001213900-25-005825-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005825/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE2yAvt2wWpdDbCYD1","market":"us","size":10176}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-01-23 13:00","pubTimestamp":1737608400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19147820","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025001208-DMAAU","pdf_url":"","pub_time":1736139600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAAU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/0001213900-25-001208-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/ea0209546-10.htm","primary":true,"translateUrl":"","linkName":"ea0209546-10.htm","type":"S-1/A","id":"NTFILE5SN6baFxLDBkyT7b","market":"us","size":141681},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/ea020954610ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954610ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE7eT3ezEaEWthCgUi","market":"us","size":2505}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2025-01-06 13:00","pubTimestamp":1736139600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19148842","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025000703-DMAAU","pdf_url":"","pub_time":1735880400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAAU","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000703/0001213900-25-000703-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000703/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEJ1UdukkJ8TxBuHVG","market":"us","size":10192}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-01-03 13:00","pubTimestamp":1735880400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19148455","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025000704-DMAAU","pdf_url":"","pub_time":1735880400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAAU","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000704/0001213900-25-000704-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000704/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHyFNV3GnE9mpRFNY","market":"us","size":9232}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-01-03 13:00","pubTimestamp":1735880400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19148345","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024106894-DMAAU","pdf_url":"","pub_time":1733720400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAAU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/0001213900-24-106894-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/ea0209546-08.htm","primary":true,"translateUrl":"","linkName":"ea0209546-08.htm","type":"S-1/A","id":"NTFILE4NahCrN2HZKKnLsz","market":"us","size":4566963},{"description":"AMENDED AND RESTATED PROMISSORY NOTE, DATED AS OF DECEMBER 5, 2024, ISSUED TO DR","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/ea020954608ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954608ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILEGRfF8smfJfw3ryY4","market":"us","size":24466}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2024-12-09 13:00","pubTimestamp":1733720400,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19151684","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024102238-DMAAU","pdf_url":"","pub_time":1732510800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAAU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/0001213900-24-102238-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea0209546-07.htm","primary":true,"translateUrl":"","linkName":"ea0209546-07.htm","type":"S-1/A","id":"NTFILEGJ4ubWyq5MdfpA1Y","market":"us","size":4578563},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILEFTLsRbuHYn6sjEQN","market":"us","size":242042},{"description":"AMENDMENT TO PROMISSORY NOTE, DATED NOVEMBER 21, 2024, ISSUED TO DRUGS MADE IN A","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex10-9_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex10-9_drugs.htm","type":"EX-10.9","id":"NTFILE6JezDYgXQ1P6xf1a","market":"us","size":10461},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILEFqrxyBCkb517t57t","market":"us","size":2138}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2024-11-25 13:00","pubTimestamp":1732510800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19151437","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024095138-DMAAU","pdf_url":"","pub_time":1730955600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAAU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/0001213900-24-095138-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 3 TO FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea0209546-06.htm","primary":true,"translateUrl":"","linkName":"ea0209546-06.htm","type":"S-1/A","id":"NTFILEBALbAiHeTS5ubaZL","market":"us","size":4384963},{"description":"FORM OF SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex3-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex3-3_drugs.htm","type":"EX-3.3","id":"NTFILEAemQyJi3Kt8s7FPe","market":"us","size":267372},{"description":"SPECIMEN UNIT CERTIFICATE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEAar6smGNdUqEtbgy","market":"us","size":19628},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-2_drugs.htm","type":"EX-4.2","id":"NTFILEFtkG5hQk3ohrTUr1","market":"us","size":17389},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN VSTOCK TRANSFER, LLC AND THE REGISTRANT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-4_drugs.htm","type":"EX-4.4","id":"NTFILE3o3aeyU8CCwjwZFg","market":"us","size":69956},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex5-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex5-1_drugs.htm","type":"EX-5.1","id":"NTFILEEXJ4xf2Nk1VedGWJ","market":"us","size":41444},{"description":"OPINION OF LOEB & LOEB LLP","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex5-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex5-2_drugs.htm","type":"EX-5.2","id":"NTFILEGonm1upYMqjXCHvS","market":"us","size":11240},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEGwA266VvaZ6JrsX6","market":"us","size":55274},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT AMONG WILMINGTON TRUST NATIONAL AS","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILEGsAcdoq2MoAwQidL","market":"us","size":101759},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND CERTAIN SECURIT","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILEFw32ZF89GrfQxFKF","market":"us","size":100105},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILE5CsM7WNQVdbwJd4s","market":"us","size":23889},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE4LH6HJ6oENg1FWkL","market":"us","size":1490},{"description":"FILING FEE TABLE","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex-fee_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex-fee_drugs.htm","type":"EX-FILING FEES","id":"NTFILE8xmhNzWSD32w6w8A","market":"us","size":17953},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEHCNvmc7MUd2JxcZF","market":"us","size":11039},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEDzURPceVT5ZSjJ95","market":"us","size":12611},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEBQ9DqBtqDo1mMsJr","market":"us","size":4190}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2024-11-07 13:00","pubTimestamp":1730955600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19077035","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024082386-DMAAU","pdf_url":"","pub_time":1727409600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAAU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/0001213900-24-082386-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea0209546-04.htm","primary":true,"translateUrl":"","linkName":"ea0209546-04.htm","type":"S-1/A","id":"NTFILEKygSu8qz3XxwzP2f","market":"us","size":4370093},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE9foF3u24s18EjC8J","market":"us","size":255602},{"description":"FORM OF SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex3-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex3-3_drugs.htm","type":"EX-3.3","id":"NTFILE7vBxk5Su9BPKxCkg","market":"us","size":267362},{"description":"SPECIMEN UNIT CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILE7bhzLPu5kAk7GyxR","market":"us","size":19918},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-2_drugs.htm","type":"EX-4.2","id":"NTFILE2ynzZen5XkQhd1Y2","market":"us","size":17378},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN VSTOCK TRANSFER, LLC AND THE REGISTRANT","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-4_drugs.htm","type":"EX-4.4","id":"NTFILE9kHJLpKT2GJhFuUa","market":"us","size":69275},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex5-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex5-1_drugs.htm","type":"EX-5.1","id":"NTFILE9yKeErv9R9scjyxU","market":"us","size":38746},{"description":"OPINION OF LOEB & LOEB LLP","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex5-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex5-2_drugs.htm","type":"EX-5.2","id":"NTFILE7XsDGso7foaeb2qH","market":"us","size":11258},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEGTxGYtAeHbvbjivR","market":"us","size":56331},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT AMONG WILMINGTON TRUST NATIONAL AS","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILE8ncKWjRdqZvwY2R4","market":"us","size":103298},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND CERTAIN SECURIT","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILEkxXhVoSW1CYRRuzR","market":"us","size":98804},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILE4ButvfEoKep4cMmq","market":"us","size":23878},{"description":"FORM OF INDEMNITY AGREEMENT","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-7_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-7_drugs.htm","type":"EX-10.7","id":"NTFILE4X2w5n2S5uCFdzKp","market":"us","size":95570},{"description":"FORM OF ADMINISTRATIVE SERVICES AGREEMENT BY AND BETWEEN THE REGISTRANT AND AN A","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-8_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-8_drugs.htm","type":"EX-10.8","id":"NTFILE7FsAqhsg6pFAuktJ","market":"us","size":14688},{"description":"FORM OF CODE OF CONDUCT","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex14_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex14_drugs.htm","type":"EX-14","id":"NTFILEHwBuSpvkoeVXXewN","market":"us","size":48800},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE25bXQcSFtC1i7fqA","market":"us","size":3959},{"description":"FORM OF AUDIT COMMITTEE CHARTER","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex99-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex99-4_drugs.htm","type":"EX-99.4","id":"NTFILE83mUXbQ4vXMG1AB3","market":"us","size":38309},{"description":"FORM OF COMPENSATION COMMITTEE CHARTER","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex99-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex99-5_drugs.htm","type":"EX-99.5","id":"NTFILE81u2sKrhaFGsTY4h","market":"us","size":31713},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEE7m1XnSyC65Mq2ED","market":"us","size":4190},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEEBj1yqhUW4Q5ZzKp","market":"us","size":11039},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEASoTJvyepY9PufX9","market":"us","size":12611}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2024-09-27 12:00","pubTimestamp":1727409600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19154716","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024076551-DMAAU","pdf_url":"","pub_time":1725595200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAAU","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076551/0001213900-24-076551-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076551/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE24wEUHY4vfoZNJVX","market":"us","size":31405},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076551/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE58kaW7GF9mAyaeHR","market":"us","size":9366}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2024-09-06 12:00","pubTimestamp":1725595200,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19076846","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024076546-DMAAU","pdf_url":"","pub_time":1725595200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAAU","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076546/0001213900-24-076546-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076546/ea0209546-02.htm","primary":true,"translateUrl":"","linkName":"ea0209546-02.htm","type":"S-1/A","id":"NTFILE8FXcs7M4A3cqdD6R","market":"us","size":4364625},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076546/ea020954602ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954602ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILEFRA5hwmDwg4Z2vNS","market":"us","size":2499}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2024-09-06 12:00","pubTimestamp":1725595200,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19077031","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024064074-DMAAU","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"DMAAU","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/0001213900-24-064074-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea0209546-01.htm","primary":true,"translateUrl":"","linkName":"ea0209546-01.htm","type":"S-1","id":"NTFILE3y5So2dJR3kiCeTA","market":"us","size":4342212},{"description":"MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex3-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex3-1_drugs.htm","type":"EX-3.1","id":"NTFILECa72gA2v45d43kmm","market":"us","size":242396},{"description":"AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex3-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex3-2_drugs.htm","type":"EX-3.2","id":"NTFILEDBQAwjMyfYAiHh8f","market":"us","size":211632},{"description":"PROMISSORY NOTE, DATED JUNE 14, 2024, ISSUED TO DRUGS MADE IN AMERICA ACQUISITIO","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILEXhQ78RcUngStbz8C","market":"us","size":19191},{"description":"SECURITIES SUBSCRIPTION AGREEMENT, DATED JUNE 14, 2024, BETWEEN THE REGISTRANT A","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex10-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex10-2_drugs.htm","type":"EX-10.2","id":"NTFILE2zMfNnhEnCbKnrK7","market":"us","size":45339},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILEFDzDV4bmNfyNPjXT","market":"us","size":3678},{"description":"CONSENT OF CATHERINE DO","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEGXCC7BKxHkcoBrvG","market":"us","size":1993},{"description":"CONSENT OF G. SRIDHAR PRASAD","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-2_drugs.htm","type":"EX-99.2","id":"NTFILEDprfA71ivGBmjEXg","market":"us","size":2022},{"description":"CONSENT OF MYRON W. SHULGAN","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-3_drugs.htm","type":"EX-99.3","id":"NTFILECxF2Fxv3iWJVFE3X","market":"us","size":2019},{"description":"FILING FEE TABLE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex-fee_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex-fee_drugs.htm","type":"EX-FILING FEES","id":"NTFILEEgKr81XqqHnstZUk","market":"us","size":17530}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"招股説明書","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMAAU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"DMAAU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMAAU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMAAU\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMAAU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMAAU","date":"2025-04-25","current":-702.852952,"percent":0,"low":-702.852952,"twenty":-702.074644,"median":-700.756969,"eighty":-700.756969,"high":-700.058307,"avg":-701.171674,"sd":0.805162,"marketCap":337182458},"quantilePoints":[{"date":"2025-04-11","current":-700.756969,"twenty":-701.036434,"median":-700.756969,"eighty":-700.058307,"marketCap":336176944},{"date":"2025-04-17","current":-700.756969,"twenty":-700.896702,"median":-700.756969,"eighty":-700.477504,"marketCap":336176944},{"date":"2025-04-25","current":-702.852952,"twenty":-702.074644,"median":-700.756969,"eighty":-700.756969,"marketCap":337182458}],"updateTime":1745762525042}}}